Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.

Haematologica

Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Italy.

Published: April 2016

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004404	PMC
http://dx.doi.org/10.3324/haematol.2015.138388	DOI Listing

Publication Analysis

brentuximab vedotin

vedotin abvd

abvd +/-

+/- radiotherapy

radiotherapy patients

patients untreated

untreated hodgkin

hodgkin lymphoma

lymphoma final

final pilot

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!